Clinical Trials Archives

PADCEVTM (enfortumab vedotin) in Combination with Keytruda (pembrolizumab) Receives Positive CHMP Opinion for the Treatment of Patients with Resectable Muscle-Invasive Bladder Cancer who are Ineligible for Cisplatin-Based Chemotherapy

Posted by James Spargo | May 22, 2026

Positive opinion is based on data from the pivotal Phase 3 EV-303 trial showing a 60% reduction in the risk of disease recurrence, progression or death and a 50% reduction in the risk of death compared to surgery alone 22 May...

STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026

Posted by James Spargo | May 22, 2026

Subset analysis shows early clinical activity supported by biomarker evidence of targeting cancer stem cell pathways driving tumor growth and progression 22 May 2026 — Cambridge, UK — STORM Therapeutics, the...

Pivotal trial data for EP0031 (A400), a next-generation Selective RET Inhibitor (SRI), in RET positive advanced NSCLC, to be presented at ASCO 2026

Posted by James Spargo | May 22, 2026

22 May 2026 — London, UK — Ellipses Pharma, a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for...

Otsuka Pharmaceuticals UK announces MHRA authorisation of new treatment option for the routine prevention of recurrent attacks of hereditary angioedema in adults and adolescents aged 12 years and older

Posted by James Spargo | May 21, 2026

The first ribonucleic acid (RNA)-targeted prophylactic therapy for patients with hereditary angioedema (HAE) to be authorised by the MHRA HAE is a rare and potentially life-threatening genetic condition affecting approximately 1...

Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis

Posted by James Spargo | May 19, 2026

UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitals Clinical observational study investigating underlying biology of endometriosis aims to uncover causal mechanisms and new druggable targets...

Directory Category: Clinical Trials

PADCEVTM (enfortumab vedotin) in Combination with Keytruda (pembrolizumab) Receives Positive CHMP Opinion for the Treatment of Patients with Resectable Muscle-Invasive Bladder Cancer who are Ineligible for Cisplatin-Based Chemotherapy

STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026

Pivotal trial data for EP0031 (A400), a next-generation Selective RET Inhibitor (SRI), in RET positive advanced NSCLC, to be presented at ASCO 2026

Otsuka Pharmaceuticals UK announces MHRA authorisation of new treatment option for the routine prevention of recurrent attacks of hereditary angioedema in adults and adolescents aged 12 years and older

Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis